1 in 4 Cancer Patients Use Cannabis — Mostly for Sleep, Pain, and Nausea

A survey of 2,602 cancer patients found 24.7% used cannabis, with sleep improvement as the primary reason, and use was 3 times more likely in advanced (Stage 4) cancer and 2.5 times more likely during chemotherapy.

RTHC-08113Cross SectionalModerate Evidence2026RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Cross-Sectional
Evidence
Moderate Evidence
Sample
N=2,602

What This Study Found

24.7% of cancer patients used cannabis; primary reason was sleep (56.7%); associated with younger age, Stage 4 cancer (OR=3.28), and concurrent chemotherapy (OR=2.45); 68% smoked/vaped, 60% used edibles, 65%+ used multiple methods.

Key Numbers

2,602 surveyed; 643 (24.7%) used cannabis; sleep: 56.7%; Stage 4 OR=3.28; chemo OR=2.45; 68% smoked/vaped; 60% edibles; 65%+ multiple methods; most spent <$100/month.

How They Did This

Cross-sectional survey of 2,602 oncology patients visiting Northern California offices from 2018-2024, with logistic regression analysis of demographics, cancer characteristics, methods, and perceived benefits.

Why This Research Matters

A quarter of cancer patients are using cannabis without robust clinical evidence guiding them — understanding their patterns and motivations is essential for developing evidence-based oncology guidance.

The Bigger Picture

The finding that sleep, not pain, is the top reason challenges assumptions — and the high rates among Stage 4 and chemotherapy patients suggest cannabis is filling real gaps in supportive care.

What This Study Doesn't Tell Us

Single region (Northern California, where cannabis is legal); self-reported use and perceived benefits; no objective outcome measures; non-Hispanic White overrepresentation in users.

Questions This Raises

  • ?Would randomized trials confirm the sleep benefits cancer patients report?
  • ?Should oncologists routinely screen for cannabis use and provide guidance?

Trust & Context

Key Stat:
Evidence Grade:
Large survey with 6-year data collection period and regression analysis, but limited by single-region self-report design without objective outcomes.
Study Age:
Published in 2026 with 2018-2024 data, capturing current cannabis use patterns among cancer patients.
Original Title:
Demographics, methods of use, and perceived benefits among patients with cancer who use cannabis.
Published In:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 34(3), 197 (2026)
Database ID:
RTHC-08113

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

A snapshot of a population at one point in time.

What do these levels mean? →

Frequently Asked Questions

How many cancer patients use cannabis?

About 1 in 4 (24.7%) in this Northern California survey. Use was significantly higher among younger patients, those with Stage 4 cancer, and those undergoing chemotherapy.

What do cancer patients use cannabis for?

Sleep improvement was the top reason (56.7%), followed by pain, nausea, and anxiety. Most patients reported perceived symptom improvements and spent less than $100 per month.

Read More on RethinkTHC

Cite This Study

RTHC-08113·https://rethinkthc.com/research/RTHC-08113

APA

Behl, Deepti; D'Andre, Stacy; Hankins, Andrea; Tiet, Kara; Portugal, Jose; Parise, Carol. (2026). Demographics, methods of use, and perceived benefits among patients with cancer who use cannabis.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 34(3), 197. https://doi.org/10.1007/s00520-026-10452-0

MLA

Behl, Deepti, et al. "Demographics, methods of use, and perceived benefits among patients with cancer who use cannabis.." Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. https://doi.org/10.1007/s00520-026-10452-0

RethinkTHC

RethinkTHC Research Database. "Demographics, methods of use, and perceived benefits among p..." RTHC-08113. Retrieved from https://rethinkthc.com/research/behl-2026-demographics-methods-of-use

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.